Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone*
- 19 June 1998
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 63 (6) , 640-645
- https://doi.org/10.1016/s0009-9236(98)90087-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole*Clinical Pharmacology & Therapeutics, 1997
- Diltiazem enhances the effects of triazolam by inhibiting its metabolism*Clinical Pharmacology & Therapeutics, 1996
- Dose of midazolam should be reduced during diltiazem and verapamil treatments.British Journal of Clinical Pharmacology, 1994
- Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen—phosphorus detection after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Pharmacokinetic Interactions with Calcium Channel Antagonists (Part II)Clinical Pharmacokinetics, 1991
- Pharmacokinetic Interactions with Calcium Channel Antagonists (Part I)1Clinical Pharmacokinetics, 1991
- High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: evaluation of their stabilityJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- BuspironeDrugs, 1986
- Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEGEuropean Journal of Clinical Pharmacology, 1983
- Comparative Effects of Diazepam and Buspirone on Subjective Feelings, Psychological Tests and the EEGInternational Pharmacopsychiatry, 1981